U.S. Congress' COVID aid plan 'within reach' as shutdown threat looms

By Patricia Zengerle and David Lawder WASHINGTON (Reuters) - Members of the U.S. Congress scrambled on Saturday to resolve the last obstacles to completing a $900 billion package of legislation to help Americans struggling with the steep health and economic costs of the coronavirus pandemic.

Reuters December 20, 2020 02:10:50 IST
U.S. Congress' COVID aid plan 'within reach' as shutdown threat looms

US Congress COVID aid plan within reach as shutdown threat looms

By Patricia Zengerle and David Lawder

WASHINGTON (Reuters) - Members of the U.S. Congress scrambled on Saturday to resolve the last obstacles to completing a $900 billion package of legislation to help Americans struggling with the steep health and economic costs of the coronavirus pandemic.

"We're right within reach," Democratic House of Representatives Speaker Nancy Pelosi told members of her party on a call discussing the overnight deal talks, according to a person who was on the call.

And in the Senate, which held an unusual weekend session as negotiations went on, Republican Majority Leader Mitch McConnell said he hoped for an agreement as soon as Saturday.

"We need to pass these measures with a big, bipartisan vote and get them signed into law without further delay," he said, calling the pandemic "an ongoing five-alarm national crisis."

Both Republicans and Democrats said the last major sticking point was a Republican-led push, spearheaded by Senator Pat Toomey this week, to rein in Federal Reserve lending programs.

"That's the big thing," Pelosi told reporters. "And that's the thing that's harmful to our economy, and pushing back an agreement on this."

Members of Congress are under intense pressure to finish the largest relief package since the early weeks of the pandemic, when Congress approved more than $4 trillion in aid. COVID-19 has killed 311,000 Americans, by far the most in the world, and put millions out of work, with unemployment rising. Economists say growth will likely remain sluggish until vaccines are widely available in mid-2021.

Adding urgency to calls for action are the looming Christmas holiday, a government shutdown possibly at midnight on Sunday and two runoff elections in Georgia on Jan. 5 that will determine whether Republicans keep control of the U.S. Senate.

Lawmakers were not sure when this weekend a deal would be announced, but no vote was expected before Sunday afternoon. John Thune, the Senate's No. 2 Republican, said the vote could slip to Monday, but that the last issues were resolveable.

"We're on the home stretch, we're on the glide path and I think we're going to get this done, and help out the American people," Thune said.

LIMITING BIDEN?

Toomey's proposal would guarantee that the Federal Reserve cannot renew emergency lending programs for small businesses and state and local governments after Jan. 1, when they expire under a coronavirus economic relief bill passed in March.

Republican opponents said those programs are an unnecessary government interference in private business and accused Democrats of seeking to extend them into 2021 as a backdoor way to provide unchecked funds for state and local governments controlled by members of their party.

Democrats in turn accused the Republicans of trying to tie the Fed's hands in order to limit Democratic President-elect Joe Biden's options for boosting the flagging economy after he takes office on Jan. 20.

The administration of Republican President Donald Trump, who insists Biden did not win the Nov. 3 election and talks of running again in 2024, said it supports Toomey's initiative.

The parties also disagree over how best to aid arts venues closed by COVID-19 restrictions, and how much emergency money should go to local governments for supplies like personal protective equipment for schools.

Many issues have been settled. The legislation is expected to include one-off $600 checks for most Americans, enhanced unemployment benefits of $300 per week, help for states distributing coronavirus vaccines and more assistance for small businesses.

The deal does not include liability protections for businesses from coronavirus -related lawsuits, a provision pushed by Republicans that has long been unacceptable to Democrats. Nor does it include the extensive aid to state and local governments Democrats wanted.

Congressional leaders plan to attach the package to a $1.4 trillion spending bill that would fund U.S. government activity through September 2021. Government funding was due to expire on Friday, but lawmakers approved a two-day stopgap bill to buy more time that Trump signed into law late on Friday.

(Reporting by Patricia Zengerle and David Lawder, Additional reporting by Richard Cowan; Writing by Patricia Zengerle and Andy Sullivan; Editing by Andrea Ricci and Grant McCool)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Target holiday sales jump 17% as shoppers splurge online
Business

Target holiday sales jump 17% as shoppers splurge online

By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.

S&P 500, Nasdaq tick higher on Intel boost
Business

S&P 500, Nasdaq tick higher on Intel boost

By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses
Business

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses

By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.